Medical Device Investing Medtronic Hugo Robotic-Assisted Surgery System Receives European CE Mark Approval
Pharmaceutical Investing Merck and Ridgeback Announce Submission of Emergency Use Authorization Application to the U.S. FDA for Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of Mild-to-Moderate COVID-19 in At Risk Adults
SHAREHOLDER ALERT: CLAIMSFILER REMINDS APPH, BMY, EAR, HYZN, INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Pharmaceutical Investing SHAREHOLDER ALERT: WeissLaw LLP Reminds XLRN, JMP, ECHO, and KDMN Shareholders About Its Ongoing Investigations
BRISTOL MYERS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY
Health Canada Approves the Use of RINVOQ® for the Treatment of Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Amgen Announces New LUMAKRAS Combination Data From Phase 1b CodeBreaK 101 Study In Patients With KRAS G12C-mutated Cancers At AACR-NCI-EORTC 2021
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
